SCHEMBL6368980

SCHEMBL6368980

Cc1cc(C)nc(Nc2nc(-c3ccccn3)cs2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN1 Q92952 2/20 0.75
KCNN2 Q9H2S1 2/20 0.75
KCNN3 Q9UGI6 2/20 0.75
SLC2A1 P11166 4/20 0.73
KMT2A Q03164 6/20 0.73
NPC1 O15118 6/20 0.73
MEN1 O00255 5/20 0.73
RAB9A P51151 5/20 0.73
MAPT P10636 4/20 0.73
NFKB1 P19838 3/20 0.73
NFKB2 Q00653 3/20 0.73
RELA Q04206 3/20 0.73
SMN1; SMN2 Q16637 3/20 0.73
TDP1 Q9NUW8 2/20 0.73
PPP1CA P62136 2/20 0.73
ALDH1A1 P00352 1/20 0.73
TP53 P04637 1/20 0.73
ALPL P05186 1/20 0.73
POLB P06746 1/20 0.73
MBD2 Q9UBB5 2/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5157963 0.86 KCNN1 (1.00) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL29601716 0.86 KCNN1 (1.00) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL4397255 0.84 KMT2A (1.00) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL30745771 0.81 KCNN1 (1.00) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL5155715 0.81 KCNN1 (1.00) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL14742535 0.81 SLC2A1 (1.00) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL7678939 0.80 MAPT (0.81) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL1890717 0.79 MAPT (0.74) KCNN1KCNN2KCNN3SLC2A1KMT2A
Bromide SCHEMBL7673197 0.79 MAPT (0.79) KCNN1KCNN2KCNN3SLC2A1KMT2A
SCHEMBL13803792 0.79 MAPT (0.78) KCNN1KCNN2KCNN3SLC2A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227989-A1 Polycyclic thiazoles as potassium ion channel modulators ICAGEN, INC. (US) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227989-A1 Polycyclic thiazoles as potassium ion channel modulators KCNJ2, KCNA3, KCNN3 KCNN1 10/4885KCNN2 6/4885KCNN3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.